Biodefence Market is projected to grow at a CAGR of 7.78% by 2033: Visiongain Reports Ltd
February 21, 2023 11:36 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Biodefence Market 2023-2033. It includes profiles of Biodefence Market and Forecasts, Market Segment by Size by Product (Vaccines {Anthrax, Smallpox,...
Biodefence Market Report 2023-2033
January 23, 2023 09:55 ET
|
ReportLinker
New York, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biodefence Market Report 2023-2033" - https://www.reportlinker.com/p06383482/?utm_source=GNW The...
Biodefence Market is projected to grow at a CAGR of 7.78% by 2033: Visiongain Reports Ltd
January 16, 2023 10:11 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Biodefence Market 2023-2033. It includes profiles of Biodefence Market and Forecasts, Market Segment by Size by Product (Vaccines {Anthrax, Smallpox,...
Biodefense Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
June 06, 2022 05:00 ET
|
Graphical Research
Pune, India, June 06, 2022 (GLOBE NEWSWIRE) -- The global biodefense market size is poised to grow at a significant CAGR during the forecast period, owing to the rising incidence of infectious...
Escherichia Coli Testing - Worldwide Industry Insights, Opportunities and Major Players 2020-2025
August 27, 2020 07:08 ET
|
Research and Markets
Dublin, Aug. 27, 2020 (GLOBE NEWSWIRE) -- The "Escherichia Coli Testing Market - Growth, Trends, and Forecasts (2020-2025)" report has been added to ResearchAndMarkets.com's offering. The global...
Premier Biomedical, Inc. Discusses CBD Public Image Challenges and the Future Marketplace with Uptick Newswire’s Stock Day Podcast
October 02, 2018 08:30 ET
|
Premier Biomedical, Inc.
PHOENIX, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTCQB:BIEI) (“Premier Biomedical, Inc.” or the “company”) is looking for new strategies and joint ventures to sell CBD. CEO and...
NanoLogix Offers EU, Hong Kong & PRC Petri FlatPack Packaging Patents For $35 - $50 Million
July 12, 2017 12:07 ET
|
NanoLogix
HUBBARD, Ohio, July 12, 2017 (GLOBE NEWSWIRE) -- NanoLogix (OTC:NNLX) is pleased to announce the offer for sale of the patents issued in the EU, Hong Kong (Patent EP269949), and the People's...
NanoLogix Rapid Bacteria Test Unveiled at CAOG, Wins Judges Choice Award; Technology Published in Journal of Infectious Diseases in Obstetrics and Gynecology
November 01, 2016 06:00 ET
|
NanoLogix Incorporated
HUBBARD, OH--(Marketwired - Nov 1, 2016) - NanoLogix, Inc. (OTC PINK: NNLX), an innovator in the rapid detection and identification of bacteria, is excited to announce the unveiling of the N-Assay,...
E. coli Testing Market to be Worth US$2.1 bn by 2022, Driven by Rising Demand for Enzyme Substrate Kits: Transparency Market Research
March 11, 2016 05:30 ET
|
Transparency Market Research
Albany, NY, March 11, 2016 (GLOBE NEWSWIRE) -- The research study from Transparency Market Research on the global E. coli testing market offers valuable insights into the market. This report is...
NanoLogix Announces Publication of a Study in Journal of Microbiology and Experimentation
January 05, 2016 06:00 ET
|
NanoLogix Incorporated
HUBBARD, OH--(Marketwired - Jan 5, 2016) - NanoLogix, Inc. (OTC PINK: NNLX), an innovator in the rapid detection, identification and determination of the antibiotic resistance and sensitivity of...